CHO Pharma, Inc. (TPEX:6586)
Taiwan · Delayed Price · Currency is TWD 36.60
-0.55 (-1.48%)
Oct 9, 2025, 2:59 PM CST
CHO Pharma Market Cap
CHO Pharma has a market cap or net worth of 7.83 billion as of October 10, 2025. Its market cap has decreased by -40.00% in one year.
Market Cap
7.83B
Enterprise Value
5.63B
Revenue
3.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
36.60
Market Cap Chart
Since September 27, 2017, CHO Pharma's market cap has decreased from 15.00B to 7.83B, a decrease of -47.78%. That is a compound annual growth rate of -7.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 7.83B | -28.93% |
| Dec 31, 2024 | 11.02B | -25.68% |
| Dec 29, 2023 | 14.83B | -41.16% |
| Dec 30, 2022 | 25.20B | 64.15% |
| Dec 30, 2021 | 15.35B | 235.65% |
| Dec 31, 2020 | 4.57B | 3.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 237.31B |
| PharmaEssentia | 198.23B |
| Bora Pharmaceuticals Co., LTD. | 80.80B |
| Lotus Pharmaceutical | 72.85B |
| Lumosa Therapeutics | 45.65B |
| Oneness Biotech | 31.42B |
| Polaris Group | 28.12B |
| Center Laboratories | 25.83B |